GSK PLC (NYSE:GSK)
$ 34.08 -0.04 (-0.12%) Market Cap: 69.61 Bil Enterprise Value: 84.95 Bil PE Ratio: 21.96 PB Ratio: 3.90 GF Score: 71/100

GlaxoSmithKline PLC at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 03:50PM GMT
Release Date Price: $38.52 (-1.24%)
James Daniel Gordon
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, and good afternoon. I'm James Gordon, JPMorgan European pharma and biotech analyst. And today, at the JPMorgan Healthcare Conference, it's my pleasure to introduce the GSK session with GSK Chief Scientific Officer and President of R&D, Hal Barron.

Today, we'll have a 20-minute presentation from Hal, and then we're going to take 20 minutes of questions. And then, we'll also be joined by other members of GSK executive team, CFO, Iain Mackay; and President of Global Pharmaceuticals, Luke Miels. And you can immediately start registering your questions. The way you do this is with the Q&A function that's associated with this presentation on the conference website. And then I'll be reading out your questions from there.

So with that said, I'd like to welcome Hal to the conference, and Hal, over to you for the presentation.

Hal V. Barron
GlaxoSmithKline plc - Chief Scientific Officer, President of R&D and Director

Good morning. Thank you,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot